Clinical Trials Logo
  1. Home
  2. Low Bone Density
  3. NCT05245851

Clinical Deployment and Validation of Rho

Low Bone Density Clinical Trial

Official title:
Clinical Deployment and Validation of Rho - An Opportunistic Osteoporosis Screening Software-as-a-Medical Device

Clinical Trial Summary

Osteoporosis is a widespread disease characterized by the loss of bone mineral density (BMD). 16 Bit has developed software, called RhoTM, that analyzes various x-rays, performed in patient age 50 and above for any clinical indication, to identify patients with low BMD. RhoTM is intended to function as a pre-screening device for low BMD. This study seeks to assess the clinical performance and impact of implementing RhoTM in real-world settings by analyzing its performance and impact on DXA referrals.

Clinical Trial Description

Osteoporosis is a widespread disease characterized by the loss of bone mineral density (BMD). 16 Bit has developed an opportunistic screening tool for low BMD, called RhoTM, that analyzes lumbar spine, thoracic spine, chest, pelvis, knee, and hand radiographs, performed in patient age 50 and above for any clinical indication to estimate lumbar and femoral neck BMD. The estimated BMD T-score is used to classify patients as having normal or low BMD. A finding of low BMD can be included in a radiologist's report, and is intended to support a discussion between healthcare provider and patient regarding the need for osteoporosis diagnosis by dual-energy x-ray absorptiometry (DXA). In this way, RhoTM is intended to function as an opportunistic pre-screening device for low BMD. This study seeks to assess the clinical performance and impact of implementing RhoTM in real-world settings by analyzing the diagnostic performance and impact on DXA referrals. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05245851
Study type Interventional
Source 16 Bit Inc.
Contact Regis Manorajah
Phone 416-480-6100
Email regis.manorajah@sunnybrook.ca
Status Recruiting
Phase N/A
Start date November 21, 2022
Completion date July 21, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT00588874 - Age Related Changes in Calciotropic Hormones and Their Impact on Male Osteoporosis
Active, not recruiting NCT05283148 - Sickle Cell Disease (SCD) Bone Pain Study N/A
Completed NCT00789503 - Nursing-Home Residents Given Bread Fortified With Vitamin D3 Phase 1/Phase 2
Completed NCT03761979 - Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults N/A
Active, not recruiting NCT05316272 - Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal Women N/A
Completed NCT00490906 - Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis N/A
Completed NCT00920075 - Alendronate in Juvenile Osteoporosis
Recruiting NCT00262184 - A Taiwan Isoflavone Multicenter Study (TIMS) N/A
Terminated NCT01656629 - Stem Cell Recruitment in Osteoporosis Therapy N/A
Recruiting NCT05330546 - Evaluation of Implant Stability in Low Quality Bone Following The Use of Osseodensifiers Versus Ridge Expanders N/A